| Serial Number | 99270216 |
| Word Mark | NON-ANIMAL NAVIGATOR |
| Filing Date | Monday, July 7, 2025 |
| Status | 647 - EXAMINERS AMENDMENT - MAILED |
| Status Date | Tuesday, January 13, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| NOT AVAILABLE | "NON-ANIMAL" |
| Goods and Services | Downloadable computer software to assist with product development, data analysis, and management in the field of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for transmitting, analyzing and generating reports; Downloadable computer software for data processing and analysis in the fields of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for research with dashboard functionality providing grid and graphical visualizations of formatted data allowing users to analyze and visually identify relationships among histopathology, clinical chemistry, and hematology findings in the field of pharmaceutical development; Downloadable computer software in the field of pharmaceutical development facilitating simultaneous analysis of formatted data from multiple studies, data querying, mining and visualization for pharmaceutical research and development using formatted data files as data sources; Downdoadable computer software for drug development research; Downloadable software for use in modeling, simulating, and predicting pharmacokinetic and toxicological outcomes to support drug development and regulatory submissions; Downloadable computer software for use in evaluating preclinical safety using in vitro, in silico, and biosimulation methodologies. |
| Goods and Services | Scientific research, namely, chemical, biochemical, and molecular analysis, research and testing services in the pharmaceutical, pharmacometrics, drug research, biotechnology and agrochemical industries, and the development and testing of new pharmaceutical products for others; Design of customized cheminformatics software for others; Consultation in the field of computer software and computer hardware design for others; Technological consultation in the field of computer networking; Software as a service (SAAS) services featuring software for data integration; Software as a service (SAAS) services featuring software for creating a network of disparate data; Software as a service (SAAS) services featuring software using artificial intelligence for data integration; Providing online non-downloadable software for data integration; Providing online non-downloadable software for creating networks of disparate data; Providing online non-downloadable software using artificial intelligence for data integration; Providing temporary use of non-downloadable computer software for integrating various databases in the fields of pharmaceuticals, pharmacometrics, drug research and logical data modeling; Providing temporary use of non-downloadable software for the collection, tracking, editing, organizing, analyzing, transmission, storage and sharing of data and information; Platform as a service (PAAS) featuring computer software platforms for predictive data analytics, data modeling and analytics; Providing online non-downloadable software for data input, integration and analytics in the fields of pharmaceuticals, pharmacometrics and drug research; Consultancy in the fields of information technology, pharmacology and software design; Software as a service (SAAS) featuring software for modeling, simulating, and analyzing biological and pharmacological data to support drug development; Providing temporary use of non-downloadable software for predicting preclinical safety outcomes using biosimulation and artificial intelligence; Consulting services in the field of scientific and technological research related to testing alternatives for pharmaceuticals; Consulting services in the field of pharmaceutical drug development, namely, advising on testing methods, toxicological data interpretation, and regulatory strategy related to preclinical safety assessment |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 7, 2025 |
| Primary Code | 009 |
| First Use Anywhere Date | Monday, April 14, 2025 |
| First Use In Commerce Date | Monday, April 14, 2025 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 7, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, April 14, 2025 |
| First Use In Commerce Date | Monday, April 14, 2025 |
| Party Name | Certara USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Radnor, PA 19087 |
| Event Date | Event Description |
| Monday, July 7, 2025 | NEW APPLICATION ENTERED |
| Monday, July 7, 2025 | APPLICATION FILING RECEIPT MAILED |
| Sunday, November 16, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 24, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, November 25, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 25, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 25, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, January 9, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, January 9, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 9, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 13, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, January 13, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, January 13, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, January 13, 2026 | ASSIGNED TO LIE |
| Wednesday, January 14, 2026 | EXAMINER'S AMENDMENT ENTERED |